frequencies – Page 9 – Communicable Diseases Research

SARS-CoV-2 seroprevalence study in Lambayeque, Peru. June–July 2020

Epidemiology

Published on 2021-04-062022-10-28
Journal: PeerJ [Category] COVID-19,

Evolution of SARS-CoV-2 genome from December 2019 to late March 2020: Emerged haplotypes and informative Tag nucleotide variations

2019년 12월부터 2020년 3월 말까지 SARS-CoV-2 게놈의 진화: 출현한 일배체형 및 유익한 Tag 뉴클레오티드 변이

Article

Published on 2021-04-012022-09-11
Journal: Journal of medical virology [Category] SARS, 유전자 메커니즘,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus Amino acid amino acid change amino acid changes analyzed cause change China contribute coronavirus country disease distribution early phase encoded protein encoded proteins Evolution frequencies Frequency group Haplotype haplotypes humans identify location majority normalized nucleotide nucleotide variations. ORF3a Receptor-binding domain regions reported S gene SARS-CoV-2 SARS-CoV-2 genome SARS-CoV-2 genome sequence sequence sequence variation sequences severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 Spread Tag Tag SNVs the receptor-binding domain Variation variations virus virus genomes
[DOI] 10.1002/jmv.26553 PMC 바로가기 [Article Type] Article

Perception of Online Lectures among Students of a Medical College in Kathmandu: A Descriptive Cross-sectional Study

Original Article

Published on 2021-03-312022-10-30
Journal: JNMA: Journal of the Nepal Medical Association [Category] Coronavirus, SARS,

‘Necessity is the mother of invention’: Specialist palliative care service innovation and practice change in response to COVID-19. Results from a multinational survey (CovPall)

Original Articles

Published on 2021-03-232022-10-29
Journal: Palliative medicine [Category] COVID-19, SARS,

Assessment of Sample Pooling for Clinical SARS-CoV-2 Testing

임상 SARS-CoV-2 테스트를 위한 샘플 풀링 평가

Article

Published on 2021-03-192022-09-11
Journal: Journal of Clinical Microbiology [Category] SARS, 치료기술,

COVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patients

COVID-19 Evidence Accelerator: 입원한 COVID-19 환자에서 아지트로마이신을 포함하거나 포함하지 않은 하이드록시클로로퀸의 사용을 설명하기 위한 병렬 분석

Research Article

Published on 2021-03-172022-09-10
Journal: PLoS ONE [Category] SARS, 치료제,

[키워드] Accelerator adjust adverse event adverse events Analysis Azithromycin best collaboration Combination COVID-19 COVID-19 pandemic Cox proportional hazard Cox proportional hazards models Data science data set data sets Effectiveness EHR Electronic health record elevated Epidemiology Evidence examined FDA foundation frequencies Friend friends health record health system hospitalized COVID-19 patient hospitalized COVID-19 patients hospitalized patient hospitalized patients Hydroxychloroquine Mortality no effect Patient pharmaceutical intervention Pharmaceutical interventions proportional hazards models Regulatory Research Result risk Seven significantly treat treated Treatment treatment group treatment groups treatment of COVID-19 use of hydroxychloroquine were used
[DOI] 10.1371/journal.pone.0248128 PMC 바로가기 [Article Type] Research Article

Presenting or Spinning Facts? Deconstructing the U.S. Centers for Disease Control Statement on the Importance of Reopening Schools Under COVID-19

Public Health

Published on 2021-03-092022-10-31
Journal: Frontiers in Public Health [Category] Coronavirus, SARS,

A Proteome-Wide Immunoinformatics Tool to Accelerate T-Cell Epitope Discovery and Vaccine Design in the Context of Emerging Infectious Diseases: An Ethnicity-Oriented Approach

신종 전염병의 맥락에서 T-세포 에피토프 발견 및 백신 설계를 가속화하기 위한 프로테옴 전체 면역정보학 도구: 민족 중심 접근

Immunology

Published on 2021-02-262022-09-11
Journal: Frontiers in Immunology [Category] MERS, 유전자 메커니즘,

[키워드] accelerate Accuracy Analysis AUC build caused CD4+ T-cell CD8+ ChAdOx1 ChAdOx1 vaccine clinical trials comparable complicate Context contribute coronavirus country Coverage COVID-19 pandemic criteria disease distribution effective Emerging infectious disease Emerging infectious diseases emerging-infectious disease Epidemics epitope epitope clusters epitope density epitope discovery epitope mapping Epitope-based vaccine Epitopes Ethnic groups Ethnicity frequencies Frequency genetic polymorphisms geographic distributions glycoprotein HLA HLA allele HLA allele frequencies HLA allele frequency HLA alleles human leukocyte antigen immune response immune responses immune responsiveness immune system immunodominant immunoinformatics in silico Infectious diseases investigated Japanese leukocyte Mortality NetMHCpan optimization Pathogens peptide Phase III clinical trials polymorphism Population predicted protein antigen protein antigens proteome Region retrieved SARS-CoV-2 SARS-CoV-2 spike glycoprotein SARS-like coronavirus spike glycoprotein T-cell T-cell epitope T-cell epitopes the SARS-CoV-2 utility vaccination Vaccination strategy Vaccinations Vaccine vaccine candidates Vaccine design vaccine-induced immune response vaccine-induced immune responses Variability Variation virus
[DOI] 10.3389/fimmu.2021.598778 PMC 바로가기 [Article Type] Immunology

A Public Health Antibody Screening Indicates a 6-Fold Higher SARS-CoV-2 Exposure Rate than Reported Cases in Children

공중 보건 항체 검사는 보고된 아동 사례보다 SARS-CoV-2 노출률이 6배 더 높음을 나타냅니다.

Article

Published on 2021-02-122022-09-11
Journal: Med (New York, N.Y.) [Category] MERS, SARS, 진단, 치료기술, 치료법,

[키워드] age antibody Antibody Response Antibody responses approach association Asymptomatic Autoimmunity capillary blood children defined diabete diabetes dried blood spot exposure family members frequencies Frequency funding Germany Health authority health screening immune immune surveillance immunoprecipitation incidence Neonate Neonates Newborn nucleocapsid nucleocapsid antigen nucleocapsid protein Nucleocapsid proteins pandemic positive Prevalence Public public health public health screening Rate RBD Receptor binding Receptor binding domain Receptor-binding domain Region SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2-positive individual SARS-CoV-2-positive individuals Screening screening program screening programs sensitivity Seroprevalence Seven Sex specificity supported Surveillance the receptor-binding domain Type 1 diabetes Variation virus was obtained were measured
[DOI] 10.1016/j.medj.2020.10.003 PMC 바로가기 [Article Type] Article

Substance use and substance use disorder, in relation to COVID-19: protocol for a scoping review

COVID-19와 관련된 물질 사용 및 물질 사용 장애: 범위 검토를 위한 프로토콜

Review

Published on 2021-02-032022-08-31
Journal: Systematic Reviews [Category] MERS, 변종, 치료제,

[키워드] Abstract affected aggravate alcohol Analysis articles Asian cannabis change CINAHL clinical clinical trial Collection conducted core coronavirus coronavirus disease COVID-19 COVID-19 pandemic creating Data analysis disaster disorder engage English language for inclusion frequencies global health Google Scholar greater Grey literature Health Organization healthcare help index Index Medicus international standard Joanna Briggs Institute literature manual middle mitigate monitoring number Nursing open Open Science Framework opioids original pandemic Population protocol PsycINFO Quantitative registry Research resulting review risk smoke social changes Standard structures substance Substance use Substance use disorder SUD supplementary material thematic analysis variant variants Web of Science WHO World Health Organization
[DOI] 10.1186/s13643-021-01605-9 PMC 바로가기 [Article Type] Review